Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0095 | 0.4076 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.0107 | 0.0086 |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0925 | 0.3874 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.0236 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0015 | 0.0015 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0107 | 0.0107 |
Trypanosoma cruzi | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0925 | 0.3874 | 1 |
Trypanosoma brucei | malonyl-CoA decarboxylase, mitochondrial precursor, putative | 0.0925 | 0.3874 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0021 | 0.0021 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0119 | 0.0119 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0.0021 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0021 | 0.5 |
Leishmania major | malonyl-coa decarboxylase-like protein | 0.0925 | 0.3874 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0015 | 0.0242 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.0218 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.0275 | 0.0275 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0025 | 0.0739 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.0218 | 1 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0025 | 0.0739 |
Wolbachia endosymbiont of Brugia malayi | malonyl-CoA decarboxylase | 0.2353 | 1 | 0.5 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0025 | 0.0679 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0129 | 0.0129 |
Loa Loa (eye worm) | hypothetical protein | 0.2353 | 1 | 1 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0038 | 0.0017 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0095 | 0.4076 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0.0021 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.0297 | 0.0277 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0021 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1259 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.9953 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.2387 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.